With Ph.D. level scientists and extensive experience in high-throughput next-generation sequencing (NGS) technologies, Creative Biolabs is dedicated to serving every unique need of our clients in NGS-related projects. Our scientists have developed an automated in-house toolkit for cancer whole-exome sequencing (WES) bioinformatic analysis. We can rapidly and reliably provide clinically relevant information from the sequencing data.

More information at: https://www.creative-biolabs.com/sup...c-analysis.htm